Earnings summaries and quarterly performance for OCCIDENTAL PETROLEUM CORP /DE/.
Executive leadership at OCCIDENTAL PETROLEUM CORP /DE/.
Vicki Hollub
President and Chief Executive Officer
Jeff Simmons
Senior Vice President and Chief Petrotechnical Officer
Kenneth Dillon
Senior Vice President and President, International Oil and Gas Operations
Nicole Clark
Vice President, Chief Compliance Officer and Corporate Secretary
Richard Jackson
Chief Operating Officer
Robert Peterson
Senior Vice President and Executive Vice President, Essential Chemistry of OxyChem
Sunil Mathew
Senior Vice President and Chief Financial Officer
Board of directors at OCCIDENTAL PETROLEUM CORP /DE/.
Research analysts who have asked questions during OCCIDENTAL PETROLEUM CORP /DE/ earnings calls.
Neil Mehta
Goldman Sachs
7 questions for OXY
Arun Jayaram
JPMorgan Chase & Co.
6 questions for OXY
Doug Leggate
Wolfe Research
5 questions for OXY
Paul Cheng
Scotiabank
5 questions for OXY
Betty Jiang
Barclays
4 questions for OXY
Leo Mariani
ROTH MKM
4 questions for OXY
Nitin Kumar
Mizuho Securities USA
3 questions for OXY
Douglas George Blyth Leggate
Wolfe Research
2 questions for OXY
James West
Evercore ISI
2 questions for OXY
Marron Guillermo Martin
JPMorgan Chase & Co.
2 questions for OXY
Matt Portillo
TPH
2 questions for OXY
Neal Dingmann
Truist Securities
2 questions for OXY
Roger Read
Wells Fargo & Company
2 questions for OXY
Scott Gruber
Citigroup
2 questions for OXY
Devin Mcdermott
Morgan Stanley
1 question for OXY
Jean Ann Salisbury
Bank of America
1 question for OXY
John Abbott
Wolfe Research
1 question for OXY
Kevin MacCurdy
Pickering Energy Partners
1 question for OXY
Matthew Portillo
Tudor, Pickering, Holt & Co.
1 question for OXY
Neal Dingnann
William Blair
1 question for OXY
Paul Chang
Scotiabank
1 question for OXY
Recent press releases and 8-K filings for OXY.
- Exceptional 2025 performance with record annual production of 1.434 million BOE/d, $300 million lower oil & gas capital spend and $275 million reduced operating expenses, generating $4.3 billion of free cash flow before working capital.
- Strengthened balance sheet via the sale of OxyChem and $4 billion debt repayment, reducing principal debt to $15 billion and targeting $14.3 billion after a $700 million tender offer.
- 2026 guidance calls for capital spending of $5.5–$5.9 billion (–$550 million vs. 2025 ex-OxyChem) to support ~1.45 million BOE/d production and deliver $1.2 billion of incremental free cash flow.
- Driving $500 million of 2026 cost savings (–7% well costs, –5% facilities, –4% domestic opex), an 8% dividend increase, and LCV Stratos phases ramping online in Q2 2026.
- Generated $0.31 adjusted EPS and a $0.07 reported loss per diluted share, delivered ~$1 billion free cash flow in Q4, and achieved the lowest quarterly U.S. operating expense at $7.77/BOE.
- Achieved 1.434 million BOE/day record production in 2025, $4.3 billion free cash flow before working capital, 107% organic reserves replacement, and reduced principal debt to $15 billion with a pending tender to $14.3 billion.
- 2026 guidance includes $5.5–$5.9 billion capital spending, 8% dividend increase, ~1.45 million BOE/day production, and over $1.2 billion free cash flow improvement driven by cost savings and lower interest.
- $4.3 billion in free cash flow before working capital with cash flow from operations up 27% (ex-OxyChem), repaid $4 billion of debt, and reduced principal debt to $15 billion with a tender offer to reach $14.3 billion.
- Set a record of 1.434 million BOE/d production, spent $300 million less on oil & gas capital, cut operating expenses by $275 million, achieved the lowest lease operating expense per BOE since 2021, and delivered a 107% organic reserves replacement ratio.
- Completed the sale of OxyChem, expanding the total resource base to 16.5 billion BOE and streamlining the portfolio toward high-margin assets.
- 2026 capital guidance of $5.5–5.9 billion (8% reduction ex-OxyChem), forecast production of 1.45 million BOE/d, and an 8% increase to the quarterly dividend.
- Occidental Petroleum commenced cash tender offers to purchase up to $700 million aggregate principal amount of senior notes and debentures, subject to a $58 million sub-cap for its Zero Coupon Senior Notes due 2036.
- The offers target five series: Zero Coupon Senior Notes due 2036 ($284.54 million), 6.125% Senior Notes due 2031 ($1,142.75 million), 6.625% Senior Notes due 2030 ($1,449.46 million), 7.200% Debentures due 2029 ($126.01 million), and 7.950% Debentures due 2029 ($80.88 million).
- Occidental is soliciting consents to eliminate certain covenants in the indentures of the 6.125% 2031, 6.625% 2030, 7.200% 2029 and 7.950% 2029 series, effective upon receipt of the requisite consents and tendering of the related notes.
- The tender offers expire at 5:00 PM ET on March 19, 2026, with an early tender deadline of March 4 2026 and pricing based on U.S. Treasury yields as of March 5, 2026.
- Occidental intends to fund the offers with cash on hand, including proceeds from the January 2, 2026 sale of Occidental Chemical Corporation.
- Occidental reported Q4 adjusted EPS of $0.31, surpassing estimates, alongside a GAAP net loss of $68 million primarily due to OxyChem sale charges.
- The sale of OxyChem to Berkshire Hathaway for $9.7 billion completed on Jan. 2, 2026, has strengthened Occidental’s balance sheet, helping reduce debt by about $5.8 billion since mid-December 2025.
- The company raised its quarterly dividend by 8.3% to $0.26, with a record date of March 10 and payment set for April 15, boosting the forward yield to approximately 2.21%.
- Occidental generated roughly $2.6 billion in operating cash flow and increased production to about 1.48 million boe/d, led by Permian growth.
- Analysts at Piper Sandler and BofA nudged their price targets up to $47 and $45 respectively, while maintaining Neutral ratings.
- Completed the sale of OxyChem on January 2, 2026, reducing debt by $5.8 billion since mid-December 2025 to $15.0 billion principal.
- Recorded a Q4 net loss of $68 million ($0.07 per diluted share) and adjusted income of $315 million ($0.31 per diluted share).
- Generated $2.6 billion of operating cash flow and $1.0 billion of free cash flow before working capital.
- Achieved production of 1,481 Mboe/d, exceeding guidance, and reported year-end proved reserves of 4.6 billion BOE with a 98% all-in and 107% organic reserves replacement ratio.
- Increased the quarterly dividend by over 8% to $0.26 per share, payable April 15, 2026.
- Occidental completed the sale of Occidental Chemical Corporation (OxyChem) on January 2, 2026; OxyChem results will be reported as discontinued operations for all periods presented in the 2025 Form 10-K.
- Q4 2025 adjusted effective tax rate is expected at 35%–37% for continuing operations and 24%–26% for discontinued operations.
- Average diluted shares outstanding in Q4 2025 totaled 1,002.9 million shares.
- Q4 2025 average realized prices: oil at $58.99/bbl worldwide versus WTI $59.14/bbl; NGL at $16.66/bbl; natural gas at $1.29/Mcf.
- On January 2, 2026, Occidental completed the sale of its chemical business, OxyChem, to Berkshire Hathaway for $9.7 billion in cash, subject to customary purchase price adjustments.
- The transaction accelerates Occidental’s strategy to strengthen its balance sheet and focus on its core oil and gas portfolio to deliver long-term value and drive innovation.
- Occidental’s subsidiary, Environmental Resource Holdings, LLC, retains OxyChem’s legacy tort claims and environmental liabilities, with Glenn Springs Holdings managing the remedial activities on its behalf.
- Occidental sold its chemical business, OxyChem, to Berkshire Hathaway for $9.7 billion in cash, subject to customary purchase price adjustments.
- The divestiture is designed to strengthen Occidental’s balance sheet and sharpen focus on its core oil and natural gas portfolio.
- Environmental Resource Holdings, LLC will retain OxyChem’s legacy tort claims and environmental liabilities, with Glenn Springs Holdings, Inc. managing remediation activities.
- Berkshire Hathaway has completed the acquisition of OxyChem from Occidental for $9.7 billion, subject to customary post-closing purchase price adjustments.
- OxyChem is a top-three U.S. manufacturer of polyvinyl chloride, chlor-alkali, chlorinated organic chemicals, and calcium chloride, with operations in the U.S., Canada, and Latin America.
- The business provides essential chemicals for water treatment, pharmaceuticals, healthcare, manufacturing, automotive, personal hygiene, and construction applications.
- OxyChem will remain under the leadership of its current president and CEO, Wade Alleman.
Fintool News
In-depth analysis and coverage of OCCIDENTAL PETROLEUM CORP /DE/.
Quarterly earnings call transcripts for OCCIDENTAL PETROLEUM CORP /DE/.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more
